Roche Diagnostics Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.9Mgeneral payments (2019-2025)
$139Kresearch payments (2019-2025)
7,704clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $938K
2020 $483K
2021 $496K
2022 $619K
2023 $505K
2024 $553K
2025 $304K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Anatomic Pathology & Clinical Pathology $874K
Infectious Disease $849K
Emergency Medicine $267K
Obstetrics & Gynecology $225K
Anatomic Pathology $211K
Cardiovascular Disease $198K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Robert Redfield Baltimore, MD Infectious Disease $638,387.00
Jason Baron Boston, MA Anatomic Pathology & Clinical Pathology $336,172.43
Sarosh Rana Chicago, IL Maternal & Fetal Medicine $79,804.33
Lawrence Weiss Aliso Viejo, CA Anatomic Pathology $49,210.00
Douglas Woelkers La Jolla, CA Obstetrics $37,220.06
David Mcclintock Ann Arbor, MI Anatomic Pathology & Clinical Pathology $30,919.21
Ambarish Pandey Dallas, TX Cardiovascular Disease $30,239.88
Christopher Baugh Boston, MA Emergency Medicine $29,862.66
Shirley Shiller Nashville, TN Anatomic Pathology & Clinical Pathology $29,482.16
Jimmy Espinoza Houston, TX Maternal & Fetal Medicine $29,206.20

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.